Tag: Bone building drugs

According to the International Osteoporosis Foundation, one in three women over 50 worldwide are affected by osteoporosis. This has prompted the development of more effective treatments, with a recent and potent new drug that rebuilds the bone, called romosozumab (Evenity), offering a significant advancement by both building new bone and slowing bone loss.

According to the American College of Rheumatology, osteoporosis is a condition where bones become weaker and more likely to break, a risk that disproportionately affects postmenopausal women. A promising recent development in tackling this condition is the **new prescription for osteoporosis**, Romosozumab (Evenity), an innovative treatment that acts in two distinct ways to improve bone health.